Acalabrutinib
Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
Leukemia & Lymphoma Society
NCCN Guidelines for Patients
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN COVID-19 Resources Page